Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- Transparency Market Research
Alcoholic Hepatitis Therapeutics Market: Overview
Alcoholic hepatitis is a kind of liver disease usually characterized by progressive inflammation of the liver due to long-term heavy intake of alcohol. Alcoholic hepatitis is generally associated with hepatosteatosis (an early stage of alcoholic liver disorder) that might lead to liver cirrhosis. The pathogenesis of the disease is not completely understood. Severely affected patients usually show symptoms such as ascites, fatigue, jaundice, hepatomegaly, hepatic encephalopathy and fever, amongst others. Currently, the alcoholic hepatitis therapeutics market is a lucrative market venture due to high patient preference and the increasing base of patients with liver diseases, which makes this industry a highly profitable and attractive market.
Alcoholic Hepatitis Therapeutics Market: Segmentation
Some of the currently available therapeutic products that are being used for the treatment of alcoholic hepatitis are as follows:
- Monoclonal antibodies
- Caspase protease inhibitor
- Hemorheologic agents
- Anabolic steroids
- Thiocarbamide compounds
- Hepatotropic hormones
- Sulfhydryl agents
- Herbal agents
Some of the pipeline therapeutics that are being developed for the treatment of alcoholic hepatitis and other liver diseases are as follows:
Alcoholic Hepatitis Therapeutics Market: Geographical Dynamics
In terms of geography, North America is the largest market for alcoholic hepatitis therapeutics owing to the high incidence of alcoholic liver diseases. Various studies suggest that more than 2 million people in the U.S. suffer from an alcoholic liver disease. However, the actual prevalence of alcoholic hepatitis is still unknown due to the asymptomatic nature of the disease and ignorance among patients for seeking medical attention. The prevalence of alcoholic hepatitis widely differs among different countries and races globally. In the Western Hemisphere, the prevalence of alcoholic hepatitis was found to be approximately 25% to 30%. However, other regions such as South East Asia, Latin America and the Middle East are expected to be the potential markets in the near future. Owing to the rising disposable income among the population and high adoption rate for novel therapeutics for liver diseases, these regions are expected to be the potential market in near future.
Alcoholic Hepatitis Therapeutics Market: Drivers and Restraints
The overall alcoholic hepatitis therapeutics market is expected to witness remarkable growth due to the increasing incidence of liver diseases and high success rate of pipeline drugs. Moreover, increasing prevalence of alcoholic liver diseases and high adoption rate for novel therapeutic products are some of the factors that are expected to fuel the demand for alcoholic hepatitis therapeutics globally. It has also been estimated that the global alcoholic hepatitis therapeutics market shows potential to be a lucrative and expanding field due to increasing mergers and acquisitions among existing and emerging pharmaceuticals companies to develop novel therapies for treating liver diseases. Additionally, expected technological breakthroughs will generate abundant opportunities for detecting liver diseases and monitoring disease progression. Furthermore, increased focus on retaining superior quality of life is one of the factors contributing to the growth of this market. However, escalating healthcare expenditure, stringent reimbursement policies and high development costs are some of the market-restraining factors that might hinder the growth of the alcoholic hepatitis therapeutics market in future.
Alcoholic Hepatitis Therapeutics Market: Key Players
Some of the major players involved with the development of alcoholic hepatitis therapeutics are Alkermes, Inc., Alfact Innovation, Conatus Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd., Galectin Therapeutics, Generon (Shanghai) Corporation Ltd., Immuron Limited, Intercept Pharmaceuticals, Inc., Lupin Laboratories Ltd., Sanofi-Aventis, Siesta Pharmaceuticals and Teva Pharmaceutical Industries Ltd.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017